Sign in
Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Monday, July 13, 2026
Sign in / Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Facebook
Instagram
Twitter
Vimeo
Youtube
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Search
Tags
Metastatic
Tag:
Metastatic
Healthcare
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast...
BFN's Desk
-
May 28, 2026
0
Healthcare
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)
BFN's Desk
-
May 27, 2026
0
Healthcare
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment...
BFN's Desk
-
May 25, 2026
0
Healthcare
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer
BFN's Desk
-
April 1, 2026
0
Healthcare
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic...
BFN's Desk
-
December 31, 2025
0
Healthcare
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast...
BFN's Desk
-
December 9, 2025
0
Healthcare
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with...
BFN's Desk
-
November 26, 2024
0
Healthcare
Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally...
BFN's Desk
-
October 8, 2024
0
Automobile
Golden Biotech’s Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients
BFN's Desk
-
January 18, 2024
0
Automobile
Final Multivariate Analysis from the Phase 3 MAGNITUDE Study Shows Trend Toward Improvement in Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer with...
BFN's Desk
-
October 22, 2023
0
1
2
Page 1 of 2
Most Read
Made-in-India Skoda Kylaq Completes 19,351-km Pune-to-Prague Drive Across 13 Countries
July 10, 2026
Sahyadri Super Specialty Hospital performs autologous stem cell transplant
July 10, 2026
XECH launches SteamX Fold hybrid garment steamer
July 10, 2026
OPPO India launches Reno16 Series with AI features
July 10, 2026